The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment
Abstract
Increasing numbers of studies indicate that free radicals and their derivatives play a role in some neuropsychiatric disorders, such as depression. The aim of this study was to investigate the activities of antioxidant enzymes, lipid peroxidation and total antioxidant status (TAS) in patients suffering from major depressive disorder (MDD) as compared to healthy controls. Specifically, we wanted to estimate how fluoxetine influences antioxidant defense and lipid peroxidation. Fifty MDD patients and thirty healthy controls participated in the study. Antioxidant enzyme activities and lipid peroxidation levels were measured in erythrocytes, while TAS was measured in plasma. All measurements were taken during an acute depressive episode and then again during depression remission after a three-month fluoxetine treatment. During acute depressive episodes, patients had significantly higher activity levels of antioxidant enzymes, such as copper-zinc superoxide dismutase (SOD1) and catalase (CAT), as compared to healthy controls. Concentrations of malondialdehyde (MDA) were also significantly higher during depressive episodes. Activity levels of glutathione peroxidase (GPx) did not differ significantly between depressed patients and healthy control subjects. Moreover, the plasma total antioxidant status of the depressed patients was decreased in comparison to control subjects. After three months of fluoxetine treatment, the above parameters did not change significantly. Major depressive disorder is accompanied by disturbances in the balance between pro- and anti-oxidative processes; however, these disturbances do not improve in patients in remission after three months of fluoxetine therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“or a significant increase in most of the studies [123, 124, 128, 129].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [124]
In the citing paper
“Also, when the modification of oxidative stress markers was followed in patients with depressive disorder after fluoxetine administration for three months, it was found that the levels of some antioxidant enzymes like Cu/Zn-SOD and CAT are significantly higher in the patients group versus the controls [124].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [124]
In the citing paper
“Individuals who suffer with MDD display lower serum/plasmatic total antioxidant potentials [28, 32, 48] and reduced brain GSH levels [31] as compared to matched controls.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
In the citing paper
“Before treatment, MDD patients displayed increased erythrocyte SOD and CAT activities, increased MDA levels, and decreased plasmatic total antioxidant status (TAS) level.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
In the citing paper
“After three months of fluoxetine treatment, MDA levels were normalized [48].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
Citations
Cites
1 retracted
Hwang, E., & Kim, G. (2006) · Toxicology · doi:10.1016/j.tox.2006.10.013 · Cited by 149
RetractedHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Benzie, I. F. F., & Strain, J. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0292 · Cited by 23,027
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Misra, H. P., & Fridovich, I. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45228-9 · Cited by 9,097
A SPECTROPHOTOMETRIC METHOD FOR MEASURING THE BREAKDOWN OF HYDROGEN PEROXIDE BY CATALASE
Beers, R. F., & Sizer, I. W. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50881-x · Cited by 6,781
Benzie, I. F. F., & Strain, J. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)99005-5 · Cited by 3,940
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Rio, D. D., Stewart, A. J., & Pellegrini, N. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.003 · Cited by 2,789
Research works printed but not linked: 1
- Bartosz, 2004, Other face of oxygen (Polish). PWN, Warsaw, 389
Cited by
Sorted by citations
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationRole of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 854
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444
Oxidative & nitrosative stress in depression: Why so much stress?
Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O'Neil, A. E., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 412
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
Oxidative stress in anxiety and comorbid disorders
Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324
Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
Maes, M. H. J., Kubera, M., Leunis, J., Berk, M., Geffard, M., & Bosmans, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01908.x · Cited by 209
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Inflammatory theory of depression
Gałecki, P., & Talarowska, M. (2018) · Psychiatria Polska · doi:10.12740/pp/76863 · Cited by 192
Self-citationNovel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E. M., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 192
de Melo, Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Gałecki, P., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 194
Self-citationMitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 193
The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs
Gałecki, P., Mossakowska-Wójcik, J., & Talarowska, M. E. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.016 · Cited by 180
Self-citationThe relevance of oxidative stress status in first episode and recurrent depression
Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
Essential elements in depression and anxiety. Part I
Młyniec, K., Davies, C. L., Sánchez, I. G. D. A., Pytka, K., Budziszewska, B., & Nowak, G. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.001 · Cited by 174
Bacterial Metabolites of Human Gut Microbiota Correlating with Depression
Averina, O. V., Zorkina, Y., Yunes, R. А., Kovtun, A. S., Ushakova, V. M., Morozova, A. Y., Kostyuk, G. P., Даниленко, В. Н., & Chekhonin, V. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239234 · Cited by 171
Human Catalase, Its Polymorphisms, Regulation and Changes of Its Activity in Different Diseases
Kodydková, J., Vávřová, L., Kocik, M., & Žák, A. (2014) · Folia Biologica · doi:10.14712/fb2014060040153 · Cited by 158
Kotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 147
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142
Gałecki, P., Gałecka, E., Maes, M., Chamielec, M., Orzechowska, A., Bobińska, K., Lewiński, A., & Szemraj, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.016 · Cited by 141
Self-citationHall, S., Desbrow, B., Anoopkumar‐Dukie, S., Davey, A. K., Arora, D. S., McDermott, C., Schubert, M. M., Perkins, A. V., Kiefel, M. J., & Grant, G. D. (2015) · Food Research International · doi:10.1016/j.foodres.2015.07.027 · Cited by 117
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
Seyedsadjadi, N., & Grant, R. (2020) · Antioxidants · doi:10.3390/antiox10010015 · Cited by 108
Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach
Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018) · Current Oncology · doi:10.3747/co.25.3790 · Cited by 99
Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain
Che, Y., Zhu, Z., Shu, Y., Zhai, C., Zhu, Y., Gong, S., Cui, Y., & Wang, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.031 · Cited by 99
Lopresti, A. L., Maes, M., Meddens, M. J. M., Maker, G. L., Arnoldussen, E., & Drummond, P. D. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.015 · Cited by 99
Budni, J., Zomkowski, A. D. E., Engel, D. F., Santos, D. B., dos Santos, A. A., Moretti, M., Valvassori, S. S., Ornell, F. R., Quevedo, J., Farina, M., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.024 · Cited by 94
Islam, M. R., Islam, M. R., Ahmed, I., Moktadir, A. A., Nahar, Z., Islam, M. S., Shahid, S. F. B., Islam, S. N., Islam, S., & Hasnat, A. (2018) · SAGE Open Medicine · doi:10.1177/2050312118773953 · Cited by 94
Holzmann, I., da Silva, L. M., da Silva, J. A. C., Steimbach, V. M. B., & de Souza, M. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.003 · Cited by 92
Protective Effects of Ascorbic Acid on Behavior and Oxidative Status of Restraint-Stressed Mice
Moretti, M., Budni, J., Santos, D. B., Antunes, A. A., Daufenbach, J. F., Manosso, L. M., Farina, M., & Rodrigues, A. L. S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9892-4 · Cited by 92
Essential elements in depression and anxiety. Part II
Młyniec, K., Gaweł, M., Doboszewska, U., Starowicz, G., Pytka, K., Davies, C. L., & Budziszewska, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.009 · Cited by 94
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 100
Maes, M. H. J., Kubera, M., Mihaylova, I., Geffard, M., Gałecki, P., Leunis, J.-C., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.039 · Cited by 87
Self-citationCamkurt, M. A., Fındıklı, E., İzci, F., Kurutaş, E. B., & Tuman, T. C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.075 · Cited by 86
Abdel-Wahab, B. A., & Salama, R. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.015 · Cited by 86
Anderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 86
Tsai, M.-C., & Huang, T. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.005 · Cited by 81
Prohan, M., Amani, R., Nematpour, S., Jomehzadeh, N., & Haghighizadeh, M. H. (2014) · Redox Report · doi:10.1179/1351000214y.0000000085 · Cited by 77
Rojas, P., Serrano-García, N., Medina-Campos, O. N., Pedraza-Chaverri, J., Ögren, S. O., & Rojas, C. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.007 · Cited by 76
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77
Impact of fluoxetine on liver damage in rats
Inkielewicz-Stępniak, I. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70510-2 · Cited by 75
Morris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 75
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2011) · PubMed · Cited by 76
Casaril, A. M., Domingues, M., Fronza, M. G., Vieira, B. M., Begnini, K. R., Lenardao, E. J., Seixas, F. K., Collares, T. V., Nogueira, C. W., & Savegnago, L. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711713 · Cited by 75
Oxidative Imbalance and Anxiety Disorders
Krolow, R., Arcego, D. M., Noschang, C. G., Weis, S. N., & Dalmaz, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223530 · Cited by 76
Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 79
A meta-analysis of lipid peroxidation markers in major depression
Lanctôt, K. L., Mazereeuw, G., Herrmann, N., Andreazza, A. C., & Khan, M. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s89922 · Cited by 69
Copper in depressive disorder: A systematic review and meta-analysis of observational studies
Ni, M., You, Y., Chen, J., & Zhang, L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.049 · Cited by 70
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
Li, X., Wu, T., Yu, Z., Li, T., Zhang, J., Zhang, Z., Cai, M., Zhang, W., Xiang, J. Y., & Cai, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.137 · Cited by 65
Gałecki, P., Szemraj, J., Bartosz, G., Bieńkiewicz, M., Gałecka, E., Florkowski, A., Lewiñski, A., & Karbownik‐Lewińska, M. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00754.x · Cited by 64
Self-citationWigner, P., Czarny, P. L., Gałecki, P., Su, K., & Śliwiński, T. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.045 · Cited by 65
Self-citationLipid Peroxidation in Psychiatric Illness: Overview of Clinical Evidence
Joshi, Y. B., & Praticò, D. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/828702 · Cited by 63
Ghosh, S., Mukherjee, S., Choudhury, S., Gupta, P., Adhikary, A., Baral, R., & Chattopadhyay, S. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.013 · Cited by 60
Shafiee, M., Ahmadnezhad, M., Tayefi, M., Arekhi, S., Vatanparast, H., Esmaily, H., Moohebati, M., Ferns, G. A., Mokhber, N., Arefhosseini, S. R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.079 · Cited by 62
Gałecki, P., Maes, M. H. J., Florkowski, A., Lewiñski, A., Gałecka, E., Bieńkiewicz, M., & Szemraj, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.005 · Cited by 59
Self-citationNovío, S., Núñez, M. J., Amigo, G., & Freire-Garabal, M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00736.x · Cited by 60
Maes, M. H. J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9326-6 · Cited by 55
Association study between plasma GDNF and cognitive function in late-onset depression
Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., & Zhang, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.043 · Cited by 55
Oxidative and Nitrosative stress in major depressive disorder: a case control study
Somani, A., Singh, A. K., Gupta, B., Nagarkoti, S., Dalal, P. K., & Dikshit, M. (2022) · Brain Sciences · doi:10.3390/brainsci12020144 · Cited by 54
Gawali, N. B., Bulani, V. D., Chowdhury, A. A., Deshpande, P. S., Nagmoti, D. M., & Juvekar, A. R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.07.004 · Cited by 56
Al-Samhari, M. M., Al-Rasheed, N. M., Al-Rejaie, S. S., Al‐Rasheed, N. M., Hasan, I. H., Mahmoud, A. M., & Dzimiri, N. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215619707 · Cited by 52
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Gardner, A., Chamielec, M., Orzechowska, A., Bobińska, K., & Kowalczyk, E. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1335-8 · Cited by 53
Self-citationSerum uric acid a depression biomarker
Meng, X., Huang, X., Deng, W., Li, J., & Li, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229626 · Cited by 51
Duda, W., Curzytek, K., Kubera, M., Iciek, M., Kowalczyk‐Pachel, D., Bilska‐Wilkosz, A., Lorenc‐Koci, E., Leśkiewicz, M., Basta‐Kaim, A., Budziszewska, B., et al. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9614-8 · Cited by 52
Altered Biochemical Parameters in Saliva of Pediatric Attention Deficit Hyperactivity Disorder
Archana, E., Pai, P., Prabhu, B., Shenoy, R. P., Prabhu, K., & Rao, A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0616-x · Cited by 50
Brew, D. W., Black, M. C., Santos, M., Rodgers, J., & Henderson, W. M. (2019) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4627 · Cited by 52
Antiulcerative effect of dexmedetomidine on indomethacin-induced gastric ulcer in rats
Polat, B., Albayrak, Y., Süleyman, B., Dursun, H., Odabaşoğlu, F., Yiğiter, M., Halıcı, Z., & Süleyman, H. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70518-7 · Cited by 47
Mellon, S. H., Wolkowitz, O. M., Schonemann, M. D., Epel, E. S., Rosser, R., Burke, H. B., Mahan, L., Reus, V. I., Stamatiou, D., Liew, C. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.79 · Cited by 46
Rappeneau, V., Wilmes, L., & Touma, C. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103555 · Cited by 47
Cordero, M. D., Alcocer‐Gómez, E., Cano‐García, F. J., de Miguel, M., Carrión, Á. M., Navas, P., & Alcázar, J. A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026915 · Cited by 46
Spiers, J. G., Chen, H. C., Bourgognon, J.-M., & Steinert, J. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.025 · Cited by 46
Baj, J., Bargieł, J., Cabaj, J., Skierkowski, B., Hunek, G., Portincasa, P., Flieger, J., & Smoleń, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015071 · Cited by 49
Arent, C. O., Réus, G. Z., Abelaira, H. M., Ribeiro, K. F., Steckert, A. V., Mina, F., Dal‐Pizzol, F., & Quevedo, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.024 · Cited by 45
Gałecki, P. (2014) · Medical Science Monitor · doi:10.12659/msm.889853 · Cited by 45
Self-citationEvaluation of oxidative and antioxidative parameters in generalized anxiety disorder
Emhan, A., Selek, S., Bayazıt, H., Karababa, İ. F., Katı, M., & Aksoy, N. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.001 · Cited by 42
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 44
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
Xia, B., Liu, X., Li, X., Wang, Y., Wang, D., Kou, R.-W., Zhang, L., Shi, R., Ye, J., Bo, X., et al. (2022) · Food & Function · doi:10.1039/d1fo03888e · Cited by 41
Liu, Z., Cai, Y., & He, J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s155144 · Cited by 40
Della, F. P., Abelaira, H. M., Réus, G. Z., Antunes, A. R., dos Santos, M. A. B., Zappellini, G., Steckert, A. V., Vuolo, F. S., Galant, L. S., Dal‐Pizzol, F., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.018 · Cited by 39
Lopes, I. S., Oliveira, I. C. M., Capibaribe, V. C. C., Valentim, J. T., da Silva, D. M. A., de Souza, A. G., de Araújo, M. A., Chaves, R. D. C., Gutierrez, S. J. C., Barbosa‐Filho, J. M., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.007 · Cited by 40
Oxidant/antioxidant imbalance is an inherent feature of depression
Talarowska, M. E., Szemraj, J., Berk, M., Maes, M. H. J., & Gałecki, P. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0454-5 · Cited by 37
Self-citationAntidepressant-like effect of celecoxib piroxicam in rat models of depression
Santiago, R. M., Barbiero, J. K., Martynhak, B. J., Boschen, S. L., da Silva, L. M., Werner, M. F. D. P., Cunha, C. D., Andreatini, R., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1159-5 · Cited by 39
Lukić, I., Mitić, M., Djordjevic, J., Tatalović, N., Bozovic, N., Soldatović, I., Mihaljevic, M. M., Pavlović, Z., Radojcic, M. B., Marić, N. P., et al. (2014) · Neuropsychobiology · doi:10.1159/000362841 · Cited by 37
Abelaira, H. M., Réus, G. Z., Ribeiro, K. F., Steckert, A. V., Mina, F., Rosa, D. V., Santana, C. V., Romano‐Silva, M. A., Dal‐Pizzol, F., & Quevedo, J. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.02.002 · Cited by 38
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35
Self-citationCamkurt, M. A., Fındıklı, E., Bakacak, M., Tolun, F. İ., & Karaaslan, M. F. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.35 · Cited by 31
Metadata
- Authors
- Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E.
- Affiliations
- Medical University of Lodz (PL)
- Corresponding author
- Gałecki, Piotr
- Venue
- Pharmacological Reports
- Published
- 2009-05
- Volume
- 61
- Issue
- 3
- Pages
- 436-447
- ISSN
- 1734-1140 (ISSN-L)
- OpenAlex
- W2062447292
- Cited by
- 214
- References
- 78
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 10 · 2020: 17 · 2019: 13 · 2018: 16 · 2017: 13 · 2016: 14 · 2015: 20 · 2014: 19 · 2013: 10 · 2012: 17
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, lipid peroxidation, antioxidant enzymes, fluoxetine, depression remission, superoxide dismutase, catalase, glutathione peroxidase, malondialdehyde, total antioxidant status, free radicals, erythrocytes, plasma
- MeSH terms
- Acute Disease, Adult, Antioxidants, Major Depressive Disorder, Female, Fluoxetine, Humans, Male, Malondialdehyde, Lipid Peroxidation, Case-Control Studies, Selective Serotonin Reuptake Inhibitors, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review